TXNIP

thioredoxin interacting protein, the group of Alpha arrestins

Basic information

Region (hg38): 1:145992435-145996579

Links

ENSG00000265972NCBI:10628OMIM:606599HGNC:16952Uniprot:Q9H3M7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TXNIP gene.

  • not_specified (52 variants)
  • not_provided (4 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TXNIP gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006472.6. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
2
missense
52
clinvar
2
clinvar
54
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 52 0 4
Loading clinvar variants...

GnomAD

Source: gnomAD

dbNSFP

Source: dbNSFP

Function
FUNCTION: May act as an oxidative stress mediator by inhibiting thioredoxin activity or by limiting its bioavailability. Interacts with COPS5 and restores COPS5-induced suppression of CDKN1B stability, blocking the COPS5-mediated translocation of CDKN1B from the nucleus to the cytoplasm. Functions as a transcriptional repressor, possibly by acting as a bridge molecule between transcription factors and corepressor complexes, and over- expression will induce G0/G1 cell cycle arrest. Required for the maturation of natural killer cells. Acts as a suppressor of tumor cell growth. Inhibits the proteasomal degradation of DDIT4, and thereby contributes to the inhibition of the mammalian target of rapamycin complex 1 (mTORC1). {ECO:0000269|PubMed:12821938, ECO:0000269|PubMed:17603038, ECO:0000269|PubMed:18541147, ECO:0000269|PubMed:21460850}.;
Pathway
NOD-like receptor signaling pathway - Homo sapiens (human);VEGFA-VEGFR2 Signaling Pathway;The NLRP3 inflammasome;Inflammasomes;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Innate Immune System;Immune System;TNFalpha (Consensus)

Recessive Scores

pRec
0.295

Intolerance Scores

loftool
0.468
rvis_EVS
0.08
rvis_percentile_EVS
60.31

Haploinsufficiency Scores

pHI
0.193
hipred
N
hipred_score
0.465
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.607

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Txnip
Phenotype
muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; vision/eye phenotype; digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; liver/biliary system phenotype; neoplasm;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;protein import into nucleus;cell cycle;response to mechanical stimulus;response to glucose;keratinocyte differentiation;response to estradiol;response to progesterone;regulation of cell population proliferation;response to hydrogen peroxide;positive regulation of apoptotic process;negative regulation of catalytic activity;platelet-derived growth factor receptor signaling pathway;response to calcium ion;negative regulation of cell division;cellular response to tumor cell
Cellular component
nucleus;cytoplasm;mitochondrial intermembrane space;cytosol
Molecular function
enzyme inhibitor activity;protein binding;ubiquitin protein ligase binding